Clinical Trial

AI in Respiratory Disease Prevention, Diagnosis, and Triage

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated April 17, 2025 (before its estimated May 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study will evaluate the impact of using the GPT-4o compared to traditional online tools in the field of respiratory disease prevention, focusing on the dissemination of knowledge and behavior changes among the general public. We will explore the effectiveness of GPT-4o in enhancing public awareness and management capabilities regarding respiratory diseases and promoting appropriate preventive behaviors.
Trial Details
NCT Number NCT06931782
Lead Sponsor The First Affiliated Hospital of Guangzhou Medical University
Conditions Respiratory Diseases, Artificial Intelligence (AI), Randomized Controlled Trial
Enrollment 2,400 participants
Start Date 2025-01-01
Primary Completion 2025-05-31 (estimated)
Study Completion 2025-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-04-17